Market Place
Sourcing Support
Pharma Deals, Investments and M&As in September 2017
In our continuous endeavor to share business intelligence that can help grow your pharmaceutical bus
Haunted: Teva’s $1.2 billion ‘pay-for-delay’ penalty; which companies will get hit next?
Teva Pharmaceutical Industries, Ltd., which acquired Cephalon in 2012, will make a total payment of
